Skip to the page

Data / Drug companies / Florrax Pharmaceutical

Florrax Pharmaceutical: 9 products in the FDA NDC directory, labeler code 84460

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Florrax Pharmaceutical (labeler code 84460) lists 9 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 8 prescription drugs, 1 over the counter drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on September 25, 2026.

The request: Watch Florrax Pharmaceutical (FDA labeler code 84460): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
84460
Products in commercial distribution
9
Packages
9
Finished drugs by generic name
5
Prescription products
8
Over the counter products
1
Flagged as original packager
7 of 7 products that carry the flag
Started marketing in the last 12 months
4
Earliest marketing start
January 13, 2023
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Other unapproved drugs888.9%
Over the counter monograph drugs111.1%

Products by type

TypeProductsShare
Prescription drugs888.9%
Over the counter drugs111.1%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Kit555.6%
Tablet333.3%
Patch111.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Torvexa84460-805KitOther unapproved drugsSeptember 25, 2026
Norixa Mini84460-910TabletOther unapproved drugsApril 28, 2026
Norvexa Mini84460-911TabletOther unapproved drugsApril 27, 2026
Floravita Mini84460-907TabletOther unapproved drugsFebruary 12, 2026
Orvexa84460-804KitOther unapproved drugsJuly 1, 2025
Orvex84460-802KitOther unapproved drugsJuly 1, 2025
Triadermex84460-100KitOther unapproved drugsJune 13, 2025
Methyl Salicylate84460-103PatchOver the counter monograph drugsFebruary 10, 2025
Calyxra84460-803KitOther unapproved drugsJanuary 13, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.